MARIZYME, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Marizyme, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2024.
  • Marizyme, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $41.6K, a 74.1% decline year-over-year.
  • Marizyme, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $251K, a 71.7% decline year-over-year.
  • Marizyme, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $527K, a 72.4% decline from 2022.
  • Marizyme, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.91M, a 112% increase from 2021.
  • Marizyme, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $898K, a 51% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $251K $41.6K -$119K -74.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $370K $54.3K -$157K -74.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-28
Q4 2023 $527K $68.7K -$173K -71.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-05-13
Q3 2023 $700K $86.1K -$185K -68.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $885K $161K -$515K -76.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.4M $211K -$505K -70.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-28
Q4 2022 $1.91M $242K -$30.2K -11.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-05-13
Q3 2022 $1.94M $272K +$207K +324% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.73M $676K +$482K +247% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 $1.25M $716K +$349K +94.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $898K $272K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $64.1K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $195K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $368K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.